Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Breast Cancer Tumor Heterogeneity

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by Anne Arundel Health System Research Institute
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Anne Arundel Health System Research Institute
ClinicalTrials.gov Identifier:
NCT02108561
First received: April 7, 2014
Last updated: July 13, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)